BIO-TECHNE Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 685.00K shares, a 528.44% increase year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 600.00K shares, a 100.00% increase year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 100.00K shares, a 50.00% decline year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 1.40M shares, a 133.33% increase year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 2.79M shares, a 130.36% increase from fiscal 2025.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.21M shares, a 46.03% decline from fiscal 2024.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.24M shares, a 41.95% increase from fiscal 2023.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.58M shares, a 35.59% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 685.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | 2.79M shares 10-K · filed 2026-08-24 |
| 2026-03-31 | 600.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | 2.21M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-12-31 | 100.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | 1.91M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-09-30 | 1.40M shares 10-Q · filed 2025-11-05 | 2.01M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2025-06-30 | 109.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | 1.21M shares 10-K · filed 2026-08-24 |
| 2025-03-31 | 300.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | 1.74M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-12-31 | 200.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | 1.84M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-09-30 | 600.00K shares 10-Q · filed 2025-11-05 | 1.81M shares derived: sum of 4 quarters · filed 2026-08-24 |
| 2024-06-30 | 640.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | 2.24M shares 10-K · filed 2026-08-24 |
| 2024-03-31 | 400.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | 1.91M shares derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-12-31 | 172.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | 1.96M shares derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-09-30 | 1.03M shares 10-Q · filed 2024-11-05 | 1.95M shares derived: sum of 4 quarters · filed 2025-08-22 |
| 2023-06-30 | 306.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | 1.58M shares 10-K · filed 2025-08-22 |
| 2023-03-31 | 456.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | 1.50M shares derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-12-31 | 154.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | 1.38M shares derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-09-30 | 660.12K shares 10-Q · filed 2023-11-07 | 2.77M shares derived: sum of 4 quarters · filed 2024-08-22 |
| 2022-06-30 | 229.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | 2.45M shares 10-K · filed 2024-08-22 |
| 2022-03-31 | 336.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | 4.22M shares derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-12-31 | 1.55M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | 4.10M shares derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-09-30 | 336.56K shares 10-Q · filed 2022-11-07 | 2.73M shares derived: sum of 4 quarters · filed 2023-08-23 |
| 2021-06-30 | 2.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | 2.51M shares 10-K · filed 2023-08-23 |
| 2021-03-31 | 211.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | 849.82K shares derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-12-31 | 176.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | 748.67K shares derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-09-30 | 116.82K shares 10-Q · filed 2021-11-08 | 766.22K shares derived: sum of 4 quarters · filed 2022-08-24 |
| 2020-06-30 | 344.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | 743.00K shares 10-K · filed 2022-08-24 |
| 2020-03-31 | 110.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | 517.33K shares derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-12-31 | 194.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | 480.97K shares derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-09-30 | 93.60K shares 10-Q · filed 2020-11-09 | 310.97K shares derived: sum of 4 quarters · filed 2021-08-25 |
| 2019-06-30 | 119.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | 383.00K shares 10-K · filed 2021-08-25 |
| 2019-03-31 | 74.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | 329.34K shares derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-12-31 | 24.00K shares 10-Q · filed 2020-02-06 | 324.51K shares derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-09-30 | 166.58K shares 10-Q · filed 2019-11-06 | 337.95K shares derived: sum of 4 quarters · filed 2020-08-26 |
| 2018-06-30 | 64.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | 204.00K shares 10-K · filed 2020-08-26 |
| 2018-03-31 | 69.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | 163.02K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | 37.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | 109.92K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-09-30 | 32.63K shares 10-Q · filed 2018-11-07 | 73.48K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-06-30 | 23.42K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | 63.00K shares 10-K/A · filed 2019-11-06 |
| 2017-03-31 | 16.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | 90.58K shares derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-12-31 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | 79.14K shares derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-09-30 | 22.14K shares 10-Q · filed 2017-11-09 | 78.64K shares derived: sum of 4 quarters · filed 2018-08-27 |
| 2016-06-30 | 51.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | 69.00K shares 10-K · filed 2018-08-27 |
| 2016-03-31 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | 18.00K shares derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | 500.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | 55.00K shares derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | 12.50K shares 10-Q · filed 2016-11-09 | 125.50K shares derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | 141.00K shares 10-K · filed 2017-09-07 |
| 2015-03-31 | 42.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | 57.14K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-12-31 | 71.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | 40.14K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-09-30 | 28.00K shares 10-Q · filed 2015-11-09 | 9.14K shares derived: sum of 4 quarters · filed 2016-08-29 |
| 2014-06-30 | -83.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | 142.00 shares 10-K · filed 2016-08-29 |
| 2014-03-31 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | |
| 2013-12-31 | 40.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | |
| 2013-09-30 | 19.00K shares 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -22.00K shares 10-K · filed 2015-08-31 | |
| 2012-09-30 | 2.00K shares 10-Q · filed 2012-11-09 | 18.00K shares derived: sum of 4 quarters · filed 2014-08-29 |
| 2012-06-30 | 4.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | 17.00K shares 10-K · filed 2014-08-29 |
| 2012-03-31 | 12.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | |
| 2011-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | |
| 2011-09-30 | 1.00K shares 10-Q · filed 2011-11-09 | |
| 2011-06-30 | 129.00K shares 10-K · filed 2013-08-29 | |
| 2010-06-30 | 73.00K shares 10-K · filed 2012-08-29 | |
| 2009-06-30 | 21.00K shares 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |